Depression and Heart Disease (World Psychiatric Association) - Softcover

Über die Autorin bzw. den Autor

Alexander Glassman is an authority on depression and antidepressant drugs, who has raised the standard of care for depressed patients. His work has clarified the safe treatment of depressed patients with cardiovascular disease:  more recently, he has been involved in studies of the relationship between depression and cardiovascular mortality.  Dr. Glassman was the recipient of the American Psychiatric Association's Foundation Fund Prize for lifetime accomplishment in Research, the Established Investigator's Award of the National Association for Research in Schizophrenia and Affective Disorders, the New York State Research Award and the 2007-2008 Anna-Monika Foundation Prize for reseach in depression. He is the author of over 300 scientific publications and serves on the editorial boards of Heart Disease and the Journal of Clinical Psychopharmacology. He is a fellow of the American College of Neuropsychopharmacology, a life fellow of the American Psychiatric Association, a member of the scientific advisory board of the National Alliance for Research on Schizophrenia and Depression (NARSAD), and a member of the scientific advisory panel of the American Legacy Panel.

Mario Maj is Professor of Psychiatry and Chairman at the University of Naples, Italy. He is President of the World Psychiatric Association and former President of the European Psychiatric Association. He is the Italian psychiatrist with the highest number of citations in indexed journals in the period 1981-2008.

Norman Sartorius is President of the International Association for the Promotion of Mental Health Programmes.  Honorary Fellow of the Royal College of Psychiatrists of the United Kingdom of Great Britain, of the Royal Australian and New Zealand College of Psychiatrists and of the American College of Psychiatry; Distinguished Fellow of the American Psychiatric Association. Member of the WHO Expert Advisory Panel on Mental Health.  Member of WPA Council.

Von der hinteren Coverseite

In recent years, there has been a growing awareness of the multiple interrelationships between depression and various physical diseases. The WPA is providing an update of currently available evidence on these interrelationships by the publication of three books, dealing with the comorbidity of depression with diabetes, heart disease and cancer.

Many patients with cardiovascular disease also experience psychiatric symptoms and distress. Patients with psychiatric problems, particularly depression, may be more susceptible to cardiovascular disorders. The presence of depression aggravates the course of the disease and is associated with reduced compliance to prescribed medications and secondary prevention measures. Cardiologists and psychiatrists therefore need an awareness of these problems and to know how to assess their effect in a given patient, how to treat one disorder in the context of another and how to manage the whole patient, not isolated symptoms.

Depression and Heart Disease is the first book devoted to the interaction between these common disorders. World leaders in cardiology and psychiatry synthesize current evidence, including some previously unpublished data, in a concise, easy-to-read format. They succinctly describe the epidemiology, pathogenesis (including cytokines and genetics) and risk factors of the comorbidity between depression and heart disease. The book also reviews the best pharmacological and psychotherapeutic approaches for people with this comorbidity.

Its practical approach makes the book ideal for all those involved in the management of these patients: psychiatrists, psychologists, cardiologists, general practitioners, cardiology specialist nurses and mental health nurses.

Aus dem Klappentext

In recent years, there has been a growing awareness of the multiple interrelationships between depression and various physical diseases. The WPA is providing an update of currently available evidence on these interrelationships by the publication of three books, dealing with the comorbidity of depression with diabetes, heart disease and cancer.

Many patients with cardiovascular disease also experience psychiatric symptoms and distress. Patients with psychiatric problems, particularly depression, may be more susceptible to cardiovascular disorders. The presence of depression aggravates the course of the disease and is associated with reduced compliance to prescribed medications and secondary prevention measures. Cardiologists and psychiatrists therefore need an awareness of these problems and to know how to assess their effect in a given patient, how to treat one disorder in the context of another and how to manage the whole patient, not isolated symptoms.

Depression and Heart Disease is the first book devoted to the interaction between these common disorders. World leaders in cardiology and psychiatry synthesize current evidence, including some previously unpublished data, in a concise, easy-to-read format. They succinctly describe the epidemiology, pathogenesis (including cytokines and genetics) and risk factors of the comorbidity between depression and heart disease. The book also reviews the best pharmacological and psychotherapeutic approaches for people with this comorbidity.

Its practical approach makes the book ideal for all those involved in the management of these patients: psychiatrists, psychologists, cardiologists, general practitioners, cardiology specialist nurses and mental health nurses.